Skip to main content

Table 2 Survival analyses of overall survival for extremity liposarcoma patients

From: Nomogram for predicting the overall survival and cancer-specific survival of patients with extremity liposarcoma: a population-based study

 

Univariate analysis

Multivariate analysis

P

HR

95.0% CI

P

Age

  < 65

Reference

Reference

   

 65–76

< 0.001

1.91

1.41–2.58

< 0.001

  > 76

< 0.001

5.64

4.23–7.53

< 0.001

Tumor size

  < 11.1

Reference

Reference

   

 11.1–23.5

0.022

1.69

1.29–2.22

< 0.001

  > 23.5

< 0.001

2.52

1.77–3.57

< 0.001

Race

 Black

Reference

    

 Other

0.426

    

 White

0.668

    

Sex

 Female

Reference

Reference

  

 Male

0.002

1.43

1.11–1.84

0.006

Histological type

 Liposarcoma, NOS

Reference

    

 Liposarcoma, well differentiated

0.001

    

 Myxoid liposarcoma

0.327

    

 Round cell liposarcoma

0.005

    

 Pleomorphic liposarcoma

< 0.001

    

 Mixed liposarcoma

0.256

    

 Fibroblastic liposarcoma

0.951

    

 Dedifferentiated liposarcoma

< 0.001

    

AJCC

 I/II

Reference

    

 III/IV

< 0.001

    

T

 T1

Reference

    

 T2

0.273

    

N

 N0

Reference

   

 N1

0.063

   

M

 M0

Reference

Reference

  

 M1

< 0.001

4.97

2.92–8.46

< 0.001

Surgery

 No

Reference

Reference

  

 Yes

< 0.001

0.33

0.20–0.55

< 0.001

Radiotherapy

 No

Reference

    

 Yes

< 0.001

    

Chemotherapy

 No

Reference

    

 Yes

< 0.001

    

Primary site

 Lower extremity

Reference

    

 Upper extremity

0.730

    

Grade

 I

Reference

Reference

   

 II

0.312

1.83

1.22–2.74

0.004

 III

< 0.001

4.90

3.53–6.80

< 0.001

 IV

< 0.001

5.85

4.27–8.02

< 0.001

  1. HR Hazard ratio, CI Confidence interval, AJCC American Joint Committee on Cancer